Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Webstep ASA: Registration of new share capital in connection with long-term incentive program

Oslo, 31 May 2022: Reference is made to the stock exchange announcement published by Webstep ASA (the "Company") on 25 May 2022, regarding the result of an exercise window for vested options under the Company's long-term incentive program and the board of directors' resolution to increase the share capital of the Company.The share capital increase pertaining to the new shares issued has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret).  The new share capital of the Company is NOK 27,461,648 divided into 27,461,648 shares, each with a

Change in the number of shares and votes in Starbreeze AB

STOCKHOLM, SWEDEN 31 May 2022 – Starbreeze AB today announces that the number of Class B shares increased by 50,000 and the number of Class A shares decreased by the same number during May due to the company’s ongoing conversion program. The number of votes decreased by 450,000. In accordance with the articles of association Class A shares shall, upon request of the holder of such shares, be converted into Class B shares. In May, 50,000 Class A shares were converted into Class B shares, which did not change the total number of shares but reduced the number of votes. As of 31 May 2022,

Moberg Pharma announces outcome of rights issue of ordinary shares

STOCKHOLM, 31 May 2022. The Board of Directors of Moberg Pharma AB (publ) (OMX: MOB) (“Moberg Pharma” or the “Company”) today announces the outcome of the fully guaranteed rights issue of ordinary shares with preferential rights for Moberg Pharma’s shareholders (the “Rights Issue”) which was resolved upon by the Board of Directors on 8 April 2022 and approved by an extraordinary general meeting on 3 May 2022. In total, 24,305,220 ordinary shares were subscribed for with support of subscription rights, corresponding to approximately 46.3 percent of the Rights Issue. 775,636 ordinary shares,

REPORT FROM THE ANNUAL GENERAL MEETING OF SCOUT GAMING GROUP

At the annual general meeting (the “AGM”) of Scout Gaming Group AB (publ), reg. no 559119-1316, (the “Company”), on May 31 2022 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the proposals, which have previously been published and are available on the Company’s website, scoutgaminggroup.com . Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability The AGM

Crunchfish signs agreement with Lenovo for XR Skeleton Stereo

Crunchfish Gesture Interaction AB ("Crunchfish") signs a commercial license agreement with Lenovo, to provide Lenovo’s new AR-glasses with Crunchfish’s latest hand tracking technology - XR Skeleton Stereo. Lenovo has integrated the software in their AR glasses to enable touchless interaction. It is a 2-years agreement, with a business model that includes an upfront fee as well as a running royalty per produced unit that includes Crunchfish’s software.The agreement gives Lenovo the right to use Crunchfish’s technology - XR Skeleton Stereo - in AR glasses and Smart glasses worldwide.

Resolutions at the annual general meeting in Nobina AB (publ)

At the annual general meeting in Nobina AB (publ) today on 31 May 2022, it was resolved on, among other things, re-election of all board members and the auditor, discharge from liability for the board members and the managing director as well as that no dividend shall be paid.Adoption of income statements and balance sheets as well as resolution on allocation of profitThe annual general meeting adopted the income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet for the financial year 2021/2022. In accordance with the board of

Nordea suspends two employees on suspicion of fraud

Following months of investigation, Nordea reported suspicions of fraud earlier this year to the police. Today the Norwegian police arrested two Norwegian Nordea employees on the suspicion of loans being issued on false grounds. Nordea is working in close cooperation with the police on the matter and has suspended the employees in question. Nordea as a company is not being investigated in this matter. - Nordea regards the arrests with the utmost seriousness and we are collaborating closely with the authorities, including the police, on the case. We are taking all necessary steps with

Sanolium AB interim report, January - March 2022

Revenue in the first quarter amounted to 205.3 (206.7) MSEK, representing a decrease of -0.7%Revenue in the first quarter amounted to 205.3 (206.7) MSEK, representing a decrease of -0.7%. Support and maintenance fees constitute the largest share of the revenue. License revenue and Professional Services revenue are attributable to the development of the existing product as well as the Sussa project. Adjusted EBITDA in the first quarter amounted to 58.2 (74.6) MSEK resulting in an adjusted EBITDA margin of 28.3 (36.1) %. Employee related expenses amounted to 111.6 (105.3) MSEK,

Report from ICA Gruppen’s 2022 Annual General Meeting

ICA Gruppen held its Annual General Meeting on 31 May 2022.ICA Gruppen’s AGM resolved upon customary AGM resolutions, including resolutions on adoption of the income statements and balance sheets for the parent company and the group, discharge from liability for the members of the Board of Directors and the CEO, election of the Board of Directors and the auditor as well as determination of board members’ and auditor’s fees. In ICA Gruppen’s interim report for the first quarter of 2022, an intention to merge Murgröna Holding AB (“Murgröna”) into ICA Gruppen AB during 2022 was communicated.

Noreco: New Share Capital Registered Following Conversion of Parts of Convertible Bond

Oslo, 31 May 2022: Reference is made to the Norwegian Energy Company ASA’s ("Noreco" or the “Company”) convertible bond loan with ISIN NO 0010851520 (the “NOR13 Bonds”) issued on 26 July 2019 and the stock exchange notice published by Noreco on 19 May 2022 with respect to the Company having received a conversion notice for NOR13 Bonds in the amount of USD 31,342,011.  The share capital increase pertaining to the conversion of the NOR13 Bonds has been registered in the Norwegian Register of Business Enterprises (Nw.: Foretaksregisteret). Following such share capital increase, the Company'

Orkla ASA – Issuance of Commercial Paper

Orkla ASA has issued two commercial papers:Amount:                      NOK 200,000,000 Start date:                   2 June 2022 Maturity:                     4 July 2022 Coupon:                      1.25 % Organised by:             DNB Markets      Amount:                      NOK 550,000,000 Start date:                   2 June 2022 Maturity:                     2 September 2022 Coupon:                      1.50 % Organised by:             DNB Markets     Orkla ASA Oslo, 31 May 2022     Ref.: Senior Vice President Group Treasury Geir

Techstep ASA - notifiable transactions in connection with Employee Share Purchase Program

Reference is made to today's announcement from Techstep ASA (the "Company") regarding a share capital increase resolved by the Board of Directors in connection with the Company's employee share purchase program (the "ESPP"). Under the ESPP, board members and employees were offered to subscribe for shares with a 20% discount of the market price at the last date of the subscription period. The application period lasted from 18 May 2022 to 27 May 2022, and the subscription price was NOK 2.344 per share. The following primary insiders have applied for and been allocated new shares in the

SCA, Vaisala and OX2 are the winners of Carnegie Sustainability Award 2022

Force of the forest, impact through measurements and renewable energy to combat environmental changes are in focus for the winners of Carnegie Sustainability Award 2022.”There are few things that will impact investor decisions more than how effectively a company can navigate the new green transition. The demand for companies with ESG integrated in the business model are enormous”,  says Lena Österberg, Head of Sustainability, Research & Strategy at Carnegie. “Both from a risk perspective as well as a business opportunity perspective”, she continues. Since 2019 Carnegie has awarded

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 31 May 2022   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Mika Saarinen Position: Chief Financial Officer Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 15691/5/4 ____________________________________________   Transaction date: 2022-05-31 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009002943 Nature of the transaction: ACQUISITION   Transaction details (1): Volume: 600 Unit price: 1.

Techstep ASA – Employee Share Purchase Program - share capital increase

Techstep ASA ("Techstep" or the "Company") has a share purchase program (the "ESPP") for all employees and board members of the Company, as approved by the annual general meeting on 21 April 2022. Under the ESPP, the members of the executive management, Board members and other employees may, in certain periods, be offered to purchase or subscribe for Techstep shares with a 20% discount of the market price at the last date of a subscription period. An application period has recently been completed, and the Company received applications for a total of 854,940 new shares in the Company.

CORRECTION: Missing MAR label and terms of loan in previous press release — CS MEDICA A/S secures 6 MDKK in loan financing to maintain momentum

CS Medica A/S issues a correction of the press release that was sent out at 11:14 CET May 31, 2022. The correction relates to the fact that the press release lacked a MAR label with reference to the EU´s Market Abuse Regulation and lacked the terms of the loan. The following MAR label should have been included in the press release:This information is information that CS MEDICA A/S is obliged to publish in accordance with the EU Market Abuse Regulation. The information was provided by the contact person above for publication on May 31, 2022, at 11:14 CET. The following terms of the loan

SLP buys modern logistics property of 8,600 sqm

SLP has today acquired and taken possession of the property Lampan 7 in Nässjö with a lettable area of approximately 8,600 sqm. The property is acquired through a corporate transaction at an underlying property value of approximately SEK 67 million. The seller is Idyllum AB.The main part of the property was built in 2019 and will be environmentally certified. The property is fully let to Lanab Group AB. The annual rent amounts to approximately SEK 3.9 million and the remaining lease term is just over 7.5 years. With today’s transaction, SLP has completed nine transactions since the

Bravida Norway acquires Bautec AS and strengthens its position in automation in Bergen

Bravida Norway acquires the company Bautec AS and thereby strengthens its position in the field of automation in Bergen. The company has sales of NOK 17 million and 13 employees.Bautec AS was founded in 2012 and specialises in building control and monitoring. It is based in Bergen and has large private and public sector clients. Bautec AS provides everything from small conversions to complete automation packages for large new buildings, and works with new installations and aftermarket services. “The acquisition of Bautec AS means that Bravida can offer very good and solid solutions in

Dicot AB enters research collaboration with Uppsala University and the W. Szafer Institute of Botany

Press release: Uppsala, May 31, 2022. Dicot AB is developing the drug candidate LIB-01, which will be a potency agent to better treat erectile dysfunction and premature ejaculation. Dicot announces today that the company has entered a research collaboration with Uppsala University and the W. Szafer Institute of Botany of the Polish Academy of Sciences (PAS) to investigate a new technology to make starting material for production of the drug substance.Dicot is developing a novel potency drug aimed to be the first choice for the treatment of erectile dysfunction and premature ejaculation. The

Endomines to start production at Pampalo open pit and reports encouraging drilling results from Friday mine

Endomines AB, stock exchange release 31 May 2022 at 13:00 CEST   Endomines is pleased to provide an operational update at its Finnish and US operations.   Pampalo Finland   Recently the gold price development has been very positive. Endomines has investigated possibilities to develop other parts and known gold deposits within the Karelian Gold Line area to increase gold production levels at the Pampalo mill. As an initial step Endomines will open the East open pit for production. The pit is planned to be in production by September 2022 and it is estimated that the East pit

SRV discloses the accurate results of a tender offer regarding the notes

SRV GROUP PLC                        STOCK EXCHANGE                    31 MAY 2022 AT 13.25 EEST SRV discloses the accurate results of a tender offer regarding the notes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. SRV Group Plc (“SRV”) announced on 28 April 2022 that it was commencing written procedures regarding potential amendments to the terms and conditions of SRV’s EUR 100 million unsecured fixed-rate notes due on 23

SRV Group Plc commences directed share issue to holders of its capital notes

SRV GROUP PLC                        INSIDE INFORMATION            31 MAY 2022 AT 13.20 EEST SRV Group Plc commences directed share issue to holders of its capital notes NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. SRV Group Plc (“SRV”) announced on 28 April 2022 that it is planning a directed share issue as a part of its programme with the aim of achieving a full reorganisation of the company’s financing. Based on an

SRV Group Plc’s board of directors resolved on a rights issue and publishes the terms and conditions of the rights issue

SRV GROUP PLC                        INSIDE INFORMATION            31 MAY 2022 AT 13.15 EEST SRV Group Plc’s board of directors resolved on a rights issue and publishes the terms and conditions of the rights issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. SRV Group Plc (“SRV”) announced on 28 April 2022 that it is planning a rights issue as a part of its programme with the aim of achieving a full reorganisation of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top